|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Ally Bridge Group NY LLC
✚
|
|
|---|---|
| CRD # | 291072 |
| SEC # | 801-121984 |
| CIK # | 0001822947 |
| AUM | $167.9 M (2025-03-31) |
| Employees | 6 (50% Investors, 0% Brokers) |
| Phone | 646-829-9373 |
| Address | 430 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0001822947 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Verona Pharma PLC | 15.2 | ||
| Capnia Inc | 15.0 | ||
| Graphite Bio Inc | 10.1 | ||
| Merus NV | 7.4 | ||
| Imara Inc | 5.6 | ||
| Oric Pharmaceuticals Inc | 4.9 | ||
| Replimune Group Inc | 4.9 | ||
| Tarsus Pharmaceuticals Inc | 4.9 | ||
| Insmed Inc | 4.8 | ||
| MIND Medicine Mindmed Inc | 4.7 | ||
| Geron Corp | 4.6 | ||
| Compass Pathways PLC | 4.2 | ||
| Centessa Pharmaceuticals PLC | 3.9 | ||
| Avidity Biosciences Inc | 3.8 | ||
| Solid Biosciences Inc | 3.5 | ||
| Lexeo Therapeutics Inc | 3.5 | ||
| Praxis Precision Medicines Inc | 3.4 | ||
| AVROBIO Inc | 3.3 | ||
| Frequency Therapeutics Inc | 1.9 | ||
| Zeta Acquisition Corp II | 1.5 | ||
| ATYR Pharma Inc | 1.5 | ||
| Monopar Therapeutics | 1.2 | ||
| Promis Neurosciences Inc | 0.6 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Ally Bridge Medalpha International Fund Limited | [2021-06-30] | 5.0 | 86.0 |
| HF | Ally Bridge Medalpha US Fund LP | [2021-06-30] | 12.8 | 2.5 |
| HF | Ally Bridge Medalpha Master Fund LP | [2019-03-28] | 5.0 | 167.9 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 167.9 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 167.9 |
| By Discretionary | ||
| Discretionary | 3 | 167.9 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 167.9 |
| By Non-United States Persons | ||
| Non-United States Persons | 164.6 | |
| United States Persons | 3.3 | |
| Total | 3 | 167.9 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 | |
|---|---|---|---|---|
| Christopher Lebeau | 34 | |||
| Martin Laufer | 69 | |||
| Jarard Blake | 15 | |||
| Fan Yu | 25 | |||
| Anna Yaeger | 3 | |||
| Robert Castrignano | 4 | |||
| Simos Simeonidis | 3 | |||
| Vimbai Gurure | 2 | |||
| Jian Xiao | 2 | |||
| Ally Bridge Group HK Limited | 2 | |||
| View All | ||||
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001822947] | |
| 3 | [0001822947] | |
| 4 | [0001822947] | |
| SC 13G | [0001822947] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Ally Bridge Group NY LLC | Cogent Biosciences Inc | [2020-11-19] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
X Cubed Capital Management LLC
✚
|
MN | 0.2 |
|
Yieldpoint LP
✚
|
NY | 0.2 |
|
Euclidean Technologies Management LLC
✚
|
WA | 0.2 |
|
Stone House Capital Management LLC
✚
|
FL | 0.2 |
|
Monimus Capital Management LP
✚
|
NJ | 0.2 |
|
Bengal Asset Management LLC
✚
|
CA | 0.2 |
|
Springhouse Capital Management LP
✚
|
0.2 | |
|
Telligent Investment Management LLC
✚
|
0.2 | |
|
Wasatch Investment Fund Manager LLC
✚
|
UT | 0.2 |
|
Staines Financial LLC
✚
|
CA | 0.2 |